Data Description
================

Purpose of data acquisition
---------------------------

Genome-wide profiles of DNA methylation have recently emerged from methylome studies carried out on more than 20 eukaryotic organisms belonging to four different lineages \[[@B1]-[@B5]\]. Promoter and gene-body methylation marks are common in higher eukaryotes where they provide an additional level of gene regulation, while inactivation of transposon and other repeated elements appears to be the main purpose of DNA methylation in fungi (reviewed by \[[@B6]\]).

The black truffle (*T. melanosporum*) is a macrofungus and a highly appreciated gastronomic delicacy produced by an ectomycorrhizal ascomycetous symbiont found throughout southern Europe. It features one the largest genomes (125 Mb), with the highest transposable element (TE) and repetitive DNA content (\>58%), amongst fungi that have been sequenced so far \[[@B7]\]. As obligate outcrossing organisms, truffles are bound to a sexual mode of propagation, which together with TEs, has been proposed to be a major force driving the evolution of DNA methylation \[[@B6],[@B8]\]. *T. melanosporum* belongs to the Pezizales, a largely unexplored group of ascomycetes that includes *Ascobolus immersus*, a fungus relying on premeiotic DNA methylation as a means to control repetitive element proliferation \[[@B9],[@B10]\].

In order to investigate how an extremely TE-rich organism, such as *T. melanosporum* exploits DNA methylation to cope with the more than 45,000 repeated elements that populate its genome \[[@B11]\], we have determined the genome-wide bisulfite sequencing (BS-seq) and RNA sequence (RNA-seq) profiles of the saprobic free-living mycelium (FLM), truffle fruitbody (FB) and ectomycorrhizal (ECM) developmental stages of this fungus (see Table [1](#T1){ref-type="table"} for a list of sequencing data and their descriptive statistics). To gain insight on the reversibility of DNA methylation and its effects on TE transcriptional activity, we determined and compared the BS-seq and RNA-seq profiles of untreated FLM and FLM treated with 5-azacytidine (5-aza), a DNA methylation inhibitor. Building on the above data, here we report the results of an in-depth investigation of the relationship between DNA methylation and transcription in genes and TEs, which led to the identification of novel transcripts from individual sample assemblies, as well as from the combined assembly. We also confirmed the relationship between copy number variation (CNV) and DNA methylation by whole-genome sequencing (WGS) of untreated genomic DNA. In this data note we describe how the samples were collected, processed for BS-seq and RNA-seq library construction and analysis, as well as subsequent data mining. We also provide an implementation of the Composite Repeat Induced Point mutation index (CRI), a dinucleotide frequency distribution analysis tool for evaluating the likelihood that DNA methylation in a given genome is induced by "Repeat-Induced Point mutation" (RIP) \[[@B12]\] (see "Availability and requirements of Software Used" for details).

###### 

Summary of sequencing data

       **Sample**        **Library**   **Number of raw reads**   **Number of uniquely mapped**   **Mapability**   **Read length**   **Coverage per strand (X)**
  --------------------- ------------- ------------------------- ------------------------------- ---------------- ----------------- -----------------------------
         **FLM**           BS-seq            122,903,319                  78,983,505                 64.26%             100                    31.61
         **FB**            BS-seq            184,692,678                  86,778,157                 46.99%             100                    34.73
         **ECM**           BS-seq            182,286,685                   3,268,721                 1.79%              90                     1.18
    **5-aza treated**      BS-seq            99,836,913                   41,349,427                 70.48%             51                     8.44
   **5-aza untreated**     BS-seq            84,315,198                   35,348,536                 70.19%             51                     7.21
         **FLM**           WG-seq            57,386,669                   45,239,191                 78.83%             51                     9.23
         **FB**            WG-seq            70,844,918                   50,646,551                 71.49%             51                     10.34
         **FLM**           RNA-seq           68,287,049                   63,751,666                 93.36%             50                      N/A
         **FB**            RNA-seq           87,310,639                   74,090,987                 84.86%             50                      N/A
    **5-aza treated**      RNA-seq           72,050,137                   60,644,746                 84.17%             51                      N/A
   **5-aza untreated**     RNA-seq           75,043,437                   62,107,389                 82.76%             51                      N/A

ECM: ECtoMycorrhiza; FB: FruitBody; FLM: Free-Living Mycelium.

Biological material
-------------------

*T. melanosporum* (Vittad.) mycelium from the Mel28 strain, the same strain utilized for reference genome sequencing \[[@B7]\], was grown on 1% malt agar (Cristomalt-D, Difal, Villefranche-sur-Saône, France) for 5 weeks before harvesting. A field-collected mature fruitbody was used for the FB library. ECM tips were from common hazel (*Corylus avellana* L.) plantlets inoculated with a *T. melanosporum* mycelium slurry (Raggi Vivai, Cesena, Italy*).* For 5-aza treatment, *T. melanosporum* mycelia were grown in the dark at 23 °C in synthetic liquid medium as described \[[@B13]\]. Every 5 days 5-aza was added to mycelia at 10, 40, and 100 μM final concentrations (from a 10 mM stock solution in water) for 45 days ('5-aza treated'), with the last addition made 24 hours before harvesting of mycelia and DNA/RNA extraction. The same volume of water, instead of 5-aza, was added to parallel control samples ('5-aza untreated').

Whole-genome bisulfite sequencing
---------------------------------

Genomic DNA (gDNA) was extracted by grinding fruitbodies in liquid nitrogen followed by purification with the DNeasy Plant Mini kit (QIAGEN, Hilden, Germany). This was followed by extraction in 50% Phenol-50% extraction buffer (100 mM Tris--HCl pH 8.0, 100 mM NaCl, 20 mM EDTA, 1% SDS) at 65 °C for 10 min and centrifugation at 14,000 rpm for 10 min. The aqueous phase was transferred to new tubes and extracted twice with phenol:chloroform (1:1) and once with chloroform. Following ethanol precipitation, samples were resuspended in H~2~O. LiCl (2 M) precipitation was used to separate RNA (pellet) from gDNA (supernatant). gDNA was precipitated with ethanol and resuspended in H~2~O. Extracted gDNA was further purified with an additional phenol:chloroform extraction and sheared by sonication to generate DNA fragments in the 150--300 bp size range. Bisulfite treatment and library preparation were carried out as described \[[@B14]\], except that the EpiTect kit (QIAGEN) was utilized for bisulfite treatment. Two consecutive rounds of conversion were performed for a total of 10 hours. The resulting libraries were sequenced by Illumina sequencing technology (Hiseq 2000 sequencer; Illumina, San Diego, CA, USA).

Processing bisulfite converted reads
------------------------------------

Bisulfite-converted reads were aligned to the reference genome (Tuber_melanosporum_v1.0) using BS Seeker 2 \[[@B15]\]. We achieved 32X, 35X and 1.2X coverage per strand for FB, FLM and ECM, respectively (see Table [1](#T1){ref-type="table"}). The ECM sample contained substantial amounts of root cells from the hazelnut host tree (*C. avellana*), whose genome has not yet been determined. Even at this low coverage, we were able to delineate global, low-resolution methylation profiles for the symbiotic (ECM) stage. Genome-wide DNA methylation profiles were generated by determining methylation levels for each cytosine in the genome. Since bisulfite treatment coupled to PCR amplification converts unmethylated cytosines (Cs) to thymines (Ts), the methylation level at each cytosine was estimated as \#C/(\#C + \#T), where \#C is the number of methylated reads and \#T is the number of unmethylated reads. The methylation level per cytosine serves as an estimate of the percentage of cells bearing a methylated cytosine at a specific locus.

For subsequent analysis we only considered cytosines that are covered by at least four reads (except for the ECM methylome, which has a considerably lower overall coverage). Table [2](#T2){ref-type="table"} shows that approximately 90% of the cytosines in FB and FLM were retained for analysis and that this percentage drops to approximately 75% for 5-aza treated and untreated. These values suggest our methylation profiles provide a good representation of the truffle methylomes (see Table [3](#T3){ref-type="table"} for the DNA methylation levels of genome, genes and transposable elements in individual BS-seq libraries).

###### 

Number of cytosines included in the methylation analysis

   **Number of cytosines\*(% genome coverage)**         **FLM**               **FB**              **ECM**        **5-aza treated**    **5-aza untreated**
  ---------------------------------------------- --------------------- --------------------- ----------------- --------------------- ---------------------
                      **CG**                      7,682,955 (92.58%)    7,444,625 (89.71%)    55,380 (0.67%)    6,594,758 (79.47%)    6,147,635 (74.08%)
                     **CHG**                      9,111,984 (93.50%)    8,829,674 (90.61%)    52,152 (0.54%)    7,739,358 (79.42%)    7,054,610 (72.39%)
                     **CHH**                      34,258,661 (91.68%)   32,954,550 (88.19%)   152,076 (0.41%)   28,932,890 (77.43%)   25,963,097 (69.48%)

ECM: ECtoMycorrhiza; FB: FruitBody; FLM: Free-Living Mycelium.

\*cytosines with reads coverage \> = 4.

###### 

Average methylation levels of genome, genes, and transposable elements

   **Methylation level\***   **FLM**   **FB**   **ECM**   **5-aza treated**   **5-aza untreated**  
  ------------------------- --------- -------- --------- ------------------- --------------------- --------
         **Genome**          **CG**    30.3%     28.9%          6.4%                 26.4%          25.3%
           **CHG**            8.1%      8.9%     3.4%           7.3%                 8.3%          
           **CHH**            10.1%    10.3%     3.3%           8.8%                 9.9%          
          **Gene**           **CG**    0.64%     0.87%          0.84%                0.68%          0.68%
           **CHG**            0.36%    0.61%     0.82%          0.39%                0.41%         
           **CHH**            0.39%    0.63%     0.95%          0.43%                0.44%         
           **TE**            **CG**    70.51%   69.71%         59.16%               72.87%          72.89%
           **CHG**           14.85%    16.50%   15.31%         13.99%               16.97%         
           **CHH**           17.27%    17.85%   17.30%         16.11%               19.24%         

ECM: ECtoMycorrhiza; FB: FruitBody; FLM: Free-Living Mycelium.

\*The methylation level is estimated based on all cytosines with reads coverage \> = 4 in each sample.

BS-seq data coverage (i.e., read depth) across the genome revealed CNVs between FLM and FB. Specifically, we identified 107 genomic regions with significant CNV (defined as a 100 kb window with a \|Log coverage ratio (FLM/FB)\| ≥0.3), corresponding to 7.3% of the genome. One hundred and two (95%) of these regions were independently confirmed by standard Illumina sequencing performed on non-bisulfite-treated FLM genomic DNA. This high coincidence rate supports the notion that BS-seq data are unbiased for CNV calling.

RNA-seq library preparation and data analysis
---------------------------------------------

Total RNA was extracted as described above, dissolved in H~2~O after LiCl precipitation and purified with the RNeasy Plant Mini kit (QIAGEN) followed by on-column DNase I digestion as per manufacturer's instructions. RNA integrity was verified with a Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA), which yielded RNA integrity number (RIN) scores of 7.0 and 6.5 for FB and FLM, respectively. RNA was quantified with the Qubit RNA BR Assay kit (Life technologies, Carlsbad, CA, USA) and 1 μg of purified RNA was utilized as starting material for library construction, which was carried out with the Illumina TruSeq RNA Sample Preparation kit as per manufacturer\'s instructions. Libraries were sequenced with an Illumina HiSeq 2000 system using 50-bp single-end reads.

The reads were mapped against transcripts of genes and TEs using Tophat \[[@B16]\] allowing up to two mismatches, and only unique alignments were kept. The quality of alignments was checked using FastQC \[[@B17]\]. The resulting alignment files were processed with the HTSeq program (version 0.5.4p3, \[[@B18]\]) to create a gene matrix for downstream analysis. Only reads mapped entirely to a single gene or TE were kept for further analysis. In our FB and FLM datasets, approximately 75% of genes are covered with a depth of at least 10 reads (see Figure [1](#F1){ref-type="fig"}A). In another set of data comparing 5-aza treated versus untreated FLM samples, about 90% of genes are covered by 10 or more reads (see Figure [1](#F1){ref-type="fig"}B), suggesting a satisfactory completeness of our data coverage. Reads corresponding to similar, but not identical repeats were also mapped, albeit with a lower ability to be mapped compared to a regular (i.e., distinct sequence element) alignment. The Venn diagrams in Figures [1](#F1){ref-type="fig"}C and [1](#F1){ref-type="fig"}D show that 55-60% of TEs are covered in both samples in the two comparisons. In total, 63,742,213 and 74,109,065 reads from FB and FLM, respectively, were uniquely mapped, corresponding to an overall 93.34% and 84.88% mapping. Expression levels were computed as Reads Per Kilobase of exon per Million reads mapped (RPKM) \[[@B19]\]. Gene length was calculated as the union length of all possible exons.

![**Coverage of RNA-seq libraries in genes and transposable elements. A**: histogram of read coverage in genes between FB and FLM libraries, and **B**: between 5-aza untreated and treated libraries. **C**: Venn diagram of read coverage in TE between FB and FLM libraries, and **D**: between 5-aza untreated and treated libraries. FB: FruitBody; FLM: Free-Living Mycelium.](2047-217X-3-25-1){#F1}

Methods
=======

Prediction of novel genes
-------------------------

We used the RNA-seq datasets listed in Table [1](#T1){ref-type="table"} (FB, FLM, FLM treated/untreated with 5-aza) to predict novel genes not included in the original annotation \[[@B20]\]. The prediction pipeline was based on a previously published approach \[[@B21]\]. First, reads were aligned to the reference genome (truffle v1.0 assembly) using TopHat \[[@B16]\], which resulted in the mapping of non-annotated regions. A guided transcript assembly using Cufflinks \[[@B22]\] with the truffle v1.0 assembly was then carried out for each sample. The resulting individual transcript assemblies were compared with the reference assembly using Cuffcompare \[[@B22]\] to identify novel transcripts.

A transcript is deemed novel if it does not overlap any known transcript in truffle v1.0 and its FPKM (Fragments Per Kilobase of exon per Million fragments mapped) value is at least four in the 95% FPKM confidence interval with a class code "u" in the output of Cuffcompare (i.e., unknown, intergenic transcript). Finally, to claim these as novel genes, the overlapping novel transcripts are clustered into a single interval, i.e., the longest transcript, that spans across all the overlapping transcripts. The clusters of overlapping novel transcripts are considered novel genes if their sequences are homologous to any known protein (BlastX analysis via Blast2GO) \[[@B23]\]. After removal of 11 extremely long genes (≥36,573 bp, the longest known gene in truffles, see Additional file [1](#S1){ref-type="supplementary-material"}: Figures S1 and S2 for the length distributions), we identified a total of 614 novel genes, 200 to 500 of which present in each sample (Table [4](#T4){ref-type="table"}). A complete list of novel genes along with expression levels and predicted protein functions are available in Additional file [2](#S2){ref-type="supplementary-material"}: Table S1.

###### 

Prediction of genes in RNA-seq datasets

     **Sample**        **Reference assembly**     **Number of novel genes**
  ----------------- ---------------------------- ---------------------------
         FB          Truffle v1.0 (7,496 genes)              282
         FLM                    328              
    5-aza treated               466              
   5-aza untreated              440              
       Merged                                                614

FB: FruitBody; FLM: Free-Living Mycelium.

DNA methylation and transcription analysis
------------------------------------------

To investigate the relationship between DNA methylation and transcription we performed a joint analysis of the BS-seq and RNA-seq data on genes and TEs. The results highlight a very different pattern between genes and TEs. As shown in Figure [2](#F2){ref-type="fig"}A, genes are mostly methylation depleted in all contexts, with no clear difference in methylation levels between genes expressed at high, medium or low levels. This argues against a possible involvement of gene body methylation in gene expression regulation. On the other hand, silenced TEs are generally highly (70-80%) methylated, and a clear anti-correlation is apparent between DNA transcription and methylation for the expressed TEs, thus suggesting TE expression regulation by DNA methylation (Figure [2](#F2){ref-type="fig"}B).

![**Integrative analysis of DNA methylation and transcription in genes and transposable elements. A**: Meta-gene plots of CG/CHG/CHH methylation level in high/med/low expression genes. **B**: Methylation level of TEs ranked by the expression level from low to high in silenced (bottom left) and expressed (bottom right) TEs. TE: Transposable elements.](2047-217X-3-25-2){#F2}

Transcriptome analysis of truffle mycelia treated with 5-aza
------------------------------------------------------------

We recently showed that mycelia treated with the demethylating agent 5-aza exhibit a 5-aza concentration-dependent transition to a fluffy-like phenotype \[[@B11]\]. 5-aza treated mycelia also displayed decreased global methylation levels compared to untreated samples. A reactivation of TE transcription was also reported. Here we performed a functional analysis of the genes differentially expressed between untreated and 5-aza treated mycelia using Blast2GO \[[@B23]\]. As revealed by this analysis, untreated vs. 5-aza treated differential transcripts are enriched in genes involved in the oxidation-reduction process and transmembrane transport. The other genes code for transcription factors or for proteins involved in metabolism, response to stimuli, and mycelium development (Table [5](#T5){ref-type="table"}). In addition to transcriptional changes, we also identified 68 novel genes/transcripts that are only present in the treated, but not in the untreated sample. Figure [3](#F3){ref-type="fig"} shows a novel gene identified in treated, but not in untreated mycelium. Together with our previous findings, this result further supports the existence of an epigenetic regulatory system operating in response to environmental stress exposure in truffles.

###### 

Differentially expressed genes between untreated and 5-aza treated mycelia

  **Gene\***                                       **Description**                                                **RPKM No aza**   **RPKM aza**   **Fold Change**   **adj. p value**
  ------------------------------------------------ ------------------------------------------------------------- ----------------- -------------- ----------------- ------------------
  ***Oxidation-reduction process***                                                                                                                                 
  GSTUMT00004482001                                Flavin-binding monooxygenase-like protein                             8              258             33.80            3.51E-09
  GSTUMT00009102001                                Extracellular dioxygenase                                            18              196             10.71            1.33E-09
  GSTUMT00002834001                                Alpha-ketoglutarate-dependent taurine dioxygenase                    47              414             8.84             4.30E-09
  GSTUMT00006862001                                Alcohol dehydrogenase 1                                             4355            34021            7.81             4.81E-08
  GSTUMT00005793001                                Bilirubin oxidase                                                   1590             8041            5.06             2.28E-05
  GSTUMT00000137001                                Cytochrome P450                                                       3               17             5.06             5.85E-04
  GSTUMT00006911001                                Multicopper oxidase                                                  19               90             4.64             4.87E-03
  GSTUMT00008228001                                Zinc-binding oxidoreductase                                          34              147             4.35             3.20E-04
  GSTUMT00002706001                                Alpha-ketoglutarate-dependent sulfonate dioxygenase protein           4               14             3.61             3.51E-02
  GSTUMT00000322001                                Fatty acid oxygenase                                                 137              48             0.35             4.81E-02
  GSTUMT00000528001                                Short-chain alcohol dehydrogenases                                   334             110             0.33             1.22E-02
  GSTUMT00007846001                                FAD binding domain-containing protein                                172              56             0.33             1.54E-02
  GSTUMT00002653001                                Pyridoxal reductase                                                  104              31             0.30             5.83E-03
  GSTUMT00000530001                                FAD binding domain-containing protein                                61               18             0.30             8.39E-03
  GSTUMT00012134001                                Dopa -dioxygenase                                                   4704             1368            0.29             3.10E-03
  GSTUMT00000158001                                Ferritin ribonucleotide reductase-like protein                       54               15             0.28             4.52E-03
  GSTUMT00002858001                                3-oxoacyl-(acyl-carrier-protein) reductase                           22               5              0.25             8.53E-03
  GSTUMT00012200001                                Malate synthase                                                      71               15             0.21             2.41E-03
  GSTUMT00001645001                                Zinc-binding alcohol                                                 219              34             0.16             1.06E-06
  GSTUMT00006980001                                Alcohol dehydrogenase                                               1022             146             0.14             1.36E-07
  GSTUMT00007117001                                D-isomer specific 2-hydroxyacid dehydrogenase                         4              0.4             0.10             4.66E-02
  ***Transmembrane transport***                                                                                                                                     
  GSTUMT00001488001                                Amino acid permease                                                  163             737             4.53             9.07E-03
  GSTUMT00003668001                                Carboxylic acid transport protein                                    20               82             4.03             6.04E-03
  GSTUMT00010777001                                Mate efflux family protein                                           16               66             4.03             1.22E-02
  GSTUMT00008972001                                Lactose permease                                                     16               64             4.02             7.12E-03
  GSTUMT00001400001                                MFS efflux transporter                                               86              295             3.44             5.58E-03
  GSTUMT00000284001                                Mg2+ transporter family-like protein                                1082             366             0.34             2.56E-02
  GSTUMT00008966001                                MFS general substrate transporter                                    27               9              0.34             4.85E-02
  GSTUMT00000070001                                MFS multidrug transporter                                            119              30             0.25             1.20E-03
  GSTUMT00004586001                                ABC transporter                                                      32               5              0.17             3.72E-02
  GSTUMT00005001001                                MFS drug efflux                                                      663              84             0.13             4.47E-08
  ***Transcription factors***                                                                                                                                       
  GSTUMT00005836001                                Fungal transcriptional regulatory protein                             1               18             17.23            1.91E-09
  GSTUMT00010369001                                STE12-like transcription factor                                       1               7              12.50            1.93E-04
  GSTUMT00004615001                                Binuclear zinc transcription factor                                   2               10             6.40             1.95E-04
  GSTUMT00004613001                                GAL4 domain-containing protein                                       90              402             4.49             1.03E-02
  GSTUMT00003504001                                C2H2 finger domain                                                  1522             467             0.31             4.98E-03
  ***Metabolic process***                                                                                                                                           
  GSTUMT00008986001                                Glycoside hydrolase family 61 protein                                0.2              5              25.60            1.10E-04
  GSTUMT00001850001                                Endo- -beta-glucanase eng1                                           94              1499            16.02            4.71E-13
  GSTUMT00012011001                                Glycoside hydrolase family 28 protein                                 7               57             7.73             3.97E-04
  GSTUMT00005539001                                Dynamin family protein                                               27              195             7.18             2.59E-05
  GSTUMT00010778001                                Agmatinase 1                                                         230             1316            5.72             1.70E-05
  GSTUMT00011981001                                Acetyltransferase                                                    298             1376            4.62             1.62E-04
  GSTUMT00007852001                                Alpha amylase                                                        166             704             4.25             6.60E-04
  GSTUMT00003032001                                Polysaccharide deacetylase                                          1222             4444            3.64             3.18E-03
  GSTUMT00001583001                                Pirin                                                                273             968             3.54             3.99E-03
  GSTUMT00005439001                                Glycerophosphoryl diester phosphodiesterase                          214             758             3.54             1.08E-02
  GSTUMT00001660001                                Glycoside hydrolase family 16 protein                                109             374             3.43             6.66E-03
  GSTUMT00006417001                                Fatty acid activator                                                 417             1410            3.38             5.16E-03
  GSTUMT00007213001                                Tat pathway signal sequence                                          74              239             3.25             1.98E-02
  GSTUMT00002512001                                Gnat family N-acetyltransferase                                      99              311             3.14             2.83E-02
  GSTUMT00000969001                                Branched-chain amino acid aminotransferase                           840             270             0.32             9.18E-03
  ***Response to stimuli/mycelium development***                                                                                                                    
  GSTUMT00004040001                                Regulator of G protein signaling domain protein                      54              209             3.84             1.40E-03
  GSTUMT00007138001                                Osmolarity two-component sensor histidine kinase SLN1                401             1134            2.83             4.81E-02
  GSTUMT00004012001                                Annexin                                                              72               23             0.33             1.38E-02
  ***Others***                                                                                                                                                      
  GSTUMT00004681001                                RNase P RPR2 RPP21 subunit domain-containing protein                 52              339             6.53             9.70E-07
  GSTUMT00002939001                                Allergenic cerato-platanin ASP F13                                   361             1730            4.80             5.46E-05
  GSTUMT00010365001                                Putative endo-glucanase                                               8               39             4.66             1.93E-02
  GSTUMT00006611001                                Protoglobin protein                                                  999             3827            3.83             3.11E-03
  GSTUMT00006718001                                Glutathione S-transferase                                            228              80             0.35             3.10E-02
  GSTUMT00008071001                                XAA-pro dipeptidase                                                 1272             413             0.32             1.27E-02
  GSTUMT00001676001                                Arrestin (or S-antigen) N-terminal domain protein                    96               31             0.32             1.22E-02
  GSTUMT00006632001                                P-loop containing nucleoside triphosphate hydrolase                 3053             724             0.24             2.20E-04

\*One hundred fifteen genes undergo a significant change in expression levels (adjusted p value \<0.05) upon 5-aza treatment. Functional annotation of the differentially expressed genes/sequences (either up- or down-regulated) was performed with the Blast2GO suite. Fifty-three genes code for hypothetical proteins. The remaining 62 genes were classified into distinct functional categories. "Oxidation-reduction process" and "transmembrane transport" appear as enriched GO terms (Fisher exact test p = 2.6E-4 and p = 7.9E-3, respectively) among differentially expressed genes.

![Screenshot of a novel gene identified in 5-aza treated mycelia.](2047-217X-3-25-3){#F3}

The composite RIP index (CRI) computation
-----------------------------------------

The composite RIP index (CRI, \[[@B12]\]; see below 'Availability and requirements of Software Used') was implemented to measure CA = \> TA enrichment within repeated sequences from *Tuber* and other organisms' genomes. The Composite RIP Index (CRI) was calculated as (RIP product)-(RIP substrate) \[[@B12]\]. The RIP product score $\left( \frac{TpA}{\mathit{ApT}} \right)$ measures the frequency of RIP products taking into account potential false positives due to local density, while the RIP substrate score $\left( \frac{CpA + TpG}{ApC + GpT} \right)$ measures the depletion of RIP targets and their reverse complement (e.g., CpA, and TpG).

To evaluate and compare CRI values in different organisms, we predicted repeats in *T. melanosporum, Neurospora crassa, Uncinocarpus reesii, Aspergillus nidulans* and *Saccharomyces cerevisiae.* Repeat annotations were predicted from the corresponding genome sequences \[[@B24]-[@B27]\] by RepeatMasker \[[@B28]\]. Further details on CRI implementation, including raw data, processed data, scripts (python and R) and output files can be accessed at \[[@B29]\].

Conclusions
===========

We provide a comprehensive genomic, epigenomic and transcriptomic sequencing data resource for the black truffle *T. melanosporum*. The use of a reversible, rather than an irreversible mechanism (such as RIP) to cope with the multitude of repeated transposable elements that populate the *T. melanosporum* genome resembles the situation in more complex organisms, including humans, and is in line with the view of a "generative" (i.e., genome-shaping) rather than a purely "destructive" role of transposable elements \[[@B30]\]. More targeted follow-up studies built upon the results of the present work may uncover variations of the DNA methylation and transposon activity profiles associated to functionally interpretable (presumably adaptive) modifications of gene expression. If extended to *T. melanosporum* specimens from different geographic areas, epigenomic analyses, such as the one described in this work, may shed light on the relationships between DNA methylation, transposon-mediated genome shaping and commercially relevant organoleptic properties, such as aroma. In addition to their general evolutionary biological implications, our findings may thus provide a new mechanistic layer to explain intraspecific variability.

Availability and requirements of Software Used
==============================================

Implementation of the Composite RIP Index
-----------------------------------------

•**Project name:** The composite RIP index (CRI) computation

•**Project home page:**<https://github.com/wwliao/critool/>

•**Operating system(s):** Platform-independent

•**Programming language:** Python and R

•**Other requirements:** Python 2.7, R

•**License:** MIT

•**Any restrictions to use by non-academics:** None

Availability of supporting data
===============================

For all sequencing data, in addition to those already described in \[[@B11]\] (GSE49700) we provide several formats to facilitate downstream data analysis: BS-seq data is presented in several formats \-- a BAM file of alignments, ATCGmap for SNP calling and coverage analysis, CGmap for methylation analysis and a wiggle file for data visualization on genome browsers, such as IGV \[[@B31]\] (see Additional file [1](#S1){ref-type="supplementary-material"}: Table S1). For WG-seq data, BAM and ATCGmap are provided. For RNA-seq data, we provide BAM files and novel genes detected from the merged transcriptome assembly (see Additional file [2](#S2){ref-type="supplementary-material"}: Table S1). All the datasets presented here are publicly available in the *GigaScience* repository, GigaDB \[[@B19]\].
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